153 related articles for article (PubMed ID: 4267738)
1. The plasminogen-plasmin system. 8. On the mechanism of chemical induction of fibrinolysis. Isolation of a latent plasminogen activator from human plasma.
Tomikawa M; Abiko Y
Thromb Diath Haemorrh; 1973 Feb; 29(1):50-62. PubMed ID: 4267738
[No Abstract] [Full Text] [Related]
2. Studies on the purification and characterization of human urinary plasminogen and plasmin.
Chen HF; Nakabayashi M; Satoh K; Sakamoto S
Thromb Haemost; 1980 Feb; 42(5):1536-47. PubMed ID: 6445089
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen and urokinase determination based on the lysis time method. Purification of the substrates--kinetic and methodological studies.
Berg W
Acta Med Scand Suppl; 1967; 478():1-45. PubMed ID: 4231608
[No Abstract] [Full Text] [Related]
4. Studies on the isolation of the multiple molecular forms of human plasminogen and plasmin by isoelectric focusing methods.
Summaria L; Arzadon L; Bernabe P; Robbins KC
J Biol Chem; 1972 Jul; 247(14):4691-702. PubMed ID: 4261400
[No Abstract] [Full Text] [Related]
5. Evidence for a role of the plasminogen activator--plasmin system in corneal ulceration.
Berman M; Leary R; Gage J
Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1204-21. PubMed ID: 6252112
[TBL] [Abstract][Full Text] [Related]
6. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
Okamoto U
Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
[No Abstract] [Full Text] [Related]
7. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.
Kaplan AP; Austen KF
J Exp Med; 1972 Dec; 136(6):1378-93. PubMed ID: 4264575
[TBL] [Abstract][Full Text] [Related]
8. Extrinsic plasminogen activator: a new principle in fibrinolysis.
Lijnen HR
Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
[TBL] [Abstract][Full Text] [Related]
9. Molecular forms of plasmin and protease inhibitors in human fibrinolytic post-mortem plasma.
Müllertz S
Scand J Clin Lab Invest; 1972 Dec; 30(4):369-79. PubMed ID: 4118172
[No Abstract] [Full Text] [Related]
10. Purification and characterization of a stimulator of plasmin generation from the antiangiogenic agent Neovastat: identification as immunoglobulin kappa light chain.
Boivin D; Provençal M; Gendron S; Ratel D; Demeule M; Gingras D; Béliveau R
Arch Biochem Biophys; 2004 Nov; 431(2):197-206. PubMed ID: 15488468
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen San Antonio: an abnormal plasminogen with a more cathodic migration, decreased activation and associated thrombosis.
Liu Y; Lyons RM; McDonagh J
Thromb Haemost; 1988 Feb; 59(1):49-53. PubMed ID: 3363534
[TBL] [Abstract][Full Text] [Related]
12. The kinin system of human plasma. VI. The action of plasmin.
Burrowes CE; Movat HZ; Soltay MJ
Proc Soc Exp Biol Med; 1971 Dec; 138(3):959-66. PubMed ID: 4257083
[No Abstract] [Full Text] [Related]
13. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
Guimarães AH; Rijken DC
Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
[TBL] [Abstract][Full Text] [Related]
14. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase.
Toki N; Takasugi S; Ishizu K; Sato H; Sumi H
Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
16. [A method for separation of plasminogen from bovine plasma fraction. I. With reference to some properties of the plasminogen].
Okamoto U; Matumoto M
Nihon Seirigaku Zasshi; 1971; 33(7):394-402. PubMed ID: 4255047
[No Abstract] [Full Text] [Related]
17. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
Wu JH; Diamond SL
J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
[TBL] [Abstract][Full Text] [Related]
18. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis--a review.
Kane KK
Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
